Lung injury, inflammation and Akt signaling following inhalation of particulate hexavalent chromium

Toxicology and Applied Pharmacology

Volumn 235, Issue 1, 2009, Pages 47-56

  Beaver, Laura M ^a   Stemmy, Erik J ^a   Constant, Stephanie L ^a   Schwartz, Arnold ^a   Little, Laura G ^b   Gigley, Jason P ^a   Chun, Gina ^a   Sugden, Kent D ^b   Ceryak, Susan M ^a   Patierno, Steven R ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MONTANA   (United States)

Author keywords

Akt; Carcinogenesis; Chromium; Hexavalent; Inflammation; Injury; Intranasal; Lung; Mouse model; Particulate

Indexed keywords

CHROMIUM; CXCL1 CHEMOKINE; INTERLEUKIN 6; PROTEIN KINASE B; UNCLASSIFIED DRUG; ZINC CHROMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; LUNG CARCINOGENESIS; LUNG INJURY; MOUSE; NONHUMAN; PARTICLE SIZE; PARTICULATE MATTER; PNEUMONIA; SIGNAL TRANSDUCTION;

ADMINISTRATION, INTRANASAL; AIR POLLUTANTS; ANIMALS; CHROMIUM; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; INHALATION EXPOSURE; LUNG DISEASES; MICE; MICE, INBRED BALB C; PARTICLE SIZE; PROTO-ONCOGENE PROTEINS C-AKT; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; MUS;

EID: 59249107053     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.11.018     Document Type: Article

References (54)

1. Albini A., and Sporn M.B. The tumour microenvironment as a target for chemoprevention. Nat. Rev., Cancer 7 (2007) 139-147
2. Altomare D.A., and Testa J.R. Perturbations of the AKT signaling pathway in human cancer. Oncogene 24 (2005) 7455-7464
3. Antonini J.M., Stone S., Roberts J.R., Chen B., Schwegler-Berry D., Afshari A.A., and Frazer D.G. Effect of short-term stainless steel welding fume inhalation exposure on lung inflammation, injury, and defense responses in rats. Toxicol. Appl. Pharmacol. 223 (2007) 234-245
4. Baron J.A., and Sandler R.S. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu. Rev. Med. 51 (2000) 511-523
5. Bellacosa A., Chan T.O., Ahmed N.N., Datta K., Malstrom S., Stokoe D., McCormick F., Feng J., and Tsichlis P. Akt activation by growth factors is a multiple-step process: the role of the pH domain. Oncogene 17 (1998) 313-325
6. Bellacosa A., Testa J.R., Staal S.P., and Tsichlis P.N. A retroviral oncogene, Akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254 (1991) 274-277
7. Brown J.R., and DuBois R.N. Cyclooxygenase as a target in lung cancer. Clin. Cancer Res. 10 (2004) 4266s-4269s
8. Chapman S.J., Cookson W.O., Musk A.W., and Lee Y.C. Benign asbestos pleural diseases. Curr. Opin. Pulm. Med. 9 (2003) 266-271
9. Cohen M.D., Zelikoff J.T., Chen L.C., and Schlesinger R.B. Immunotoxicologic effects of inhaled chromium: role of particle solubility and co-exposure to ozone. Toxicol. Appl. Pharmacol. 152 (1998) 30-40
10. Coussens L.M., and Werb Z. Inflammatory cells and cancer: think different!. J. Exp. Med. 193 (2001) F23-F26
11. Dalager N.A., Mason T.J., Fraumeni Jr. J.F., Hoover R., and Payne W.W. Cancer mortality among workers exposed to zinc chromate paints. J. Occup. Med. 22 (1980) 25-29
12. Daniels C.E., and Jett J.R. Does interstitial lung disease predispose to lung cancer?. Curr. Opin. Pulm. Med. 11 (2005) 431-437
13. Eyles J.E., Spiers I.D., Williamson E.D., and Alpar H.O. Tissue distribution of radioactivity following intranasal administration of radioactive microspheres. J. Pharm. Pharmacol. 53 (2001) 601-607
14. Fishbein L. Sources, transport and alterations of metal compounds: an overview. I. Arsenic, beryllium, cadmium, chromium, and nickel. Environ. Health Perspect. 40 (1981) 43-64
15. Garcia-Rodriguez L.A., and Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 12 (2001) 88-93
16. Gwinn W.M., Damsker J.M., Falahati R., Okwumabua I., Kelly-Welch A., Keegan A.D., Vanpouille C., Lee J.J., Dent L.A., Leitenberg D., Bukrinsky M.I., and Constant S.L. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. J. Immunol. 177 (2006) 4870-4879
17. Hansen M.B., Johansen J.D., and Menne T. Chromium allergy: significance of both Cr(III) and Cr(VI). Contact Dermatitis 49 (2003) 206-212
18. Hold G.L., and El Omar M.E. Genetic aspects of inflammation and cancer. Biochem. J. 410 (2008) 225-235
19. Hueper W.C., and Payne W.W. Experimental cancers in rats produced by chromium compounds and their significance to industry and public health. Am. Ind. Hyg. Assoc. J. 20 (1959) 274-280
20. Ishikawa Y., Nakagawa K., Satoh Y., Kitagawa T., Sugano H., Hirano T., and Tsuchiya E. "Hot spots" of chromium accumulation at bifurcations of chromate workers' bronchi. Cancer Res. 54 (1994) 2342-2346
21. Ishikawa Y., Nakagawa K., Satoh Y., Kitagawa T., Sugano H., Hirano T., and Tsuchiya E. Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions: an autopsy study. Br. J. Cancer 70 (1994) 160-166
22. Iyer V.J., Banerjee G., Govindram C.B., Kamath V., Shinde S., Gaikwad A., Jerajani H.R., Raman G., and Cherian K.M. Role of different valence states of chromium in the elicitation of allergic contact dermatitis. Contact Dermatitis 47 (2002) 357-360
23. Khuder S.A., Herial N.A., Mutgi A.B., and Federman D.J. Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis. Chest 127 (2005) 748-754
24. Lai J.P., Dalton J.T., and Knoell D.L. Phosphatase and tensin homologue deleted on chromosome ten (PTEN) as a molecular target in lung epithelial wound repair. Br. J. Pharmacol. 152 (2007) 1172-1184
25. Lee H.Y., Oh S.H., Woo J.K., Kim W.Y., Van Pelt C.S., Price R.E., Cody D., Tran H., Pezzuto J.M., Moriarty R.M., and Hong W.K. Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis. J. Natl. Cancer Inst. 97 (2005) 1695-1699
26. Levy L.S., and Venitt S. Carcinogenicity and mutagenicity of chromium compounds: the association between bronchial metaplasia and neoplasia. Carcinogenesis 7 (1986) 831-835
27. Li L.F., Liao S.K., Lee C.H., Huang C.C., and Quinn D.A. Involvement of Akt and endothelial nitric oxide synthase in ventilation-induced neutrophil infiltration: a prospective, controlled animal experiment. Crit. Care 11 (2007) R89
28. Lu Y., Parkyn L., Otterbein L.E., Kureishi Y., Walsh K., Ray A., and Ray P. Activated Akt protects the lung from oxidant-induced injury and delays death of mice. J. Exp. Med. 193 (2001) 545-549
29. Malkinson A.M. Role of inflammation in mouse lung tumorigenesis: a review. Exp. Lung Res. 31 (2005) 57-82
30. Mossman B.T., and Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit. Care Med. 157 (1998) 1666-1680
31. O'Brien T.J., Ceryak S., and Patierno S.R. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat. Res. 533 (2003) 3-36
32. O'Hara K.A., Klei L.R., and Barchowsky A. Selective activation of Src family kinases and JNK by low levels of chromium(VI). Toxicol. Appl. Pharmacol. 190 (2003) 214-223
33. O'Hara K.A., Nemec A.A., Alam J., Klei L.R., Mossman B.T., and Barchowsky A. Chromium (VI) inhibits heme oxygenase-1 expression in vivo and in arsenic-exposed human airway epithelial cells. J. Cell Physiol. 209 (2006) 113-121
34. O'Hara K.A., Vaghjiani R.J., Nemec A.A., Klei L.R., and Barchowsky A. Cr(VI)-stimulated STAT3 tyrosine phosphorylation and nuclear translocation in human airway epithelial cells requires Lck. Biochem. J. 402 (2007) 261-269
35. PHS US Department of Health and Human Services A.F.T.S.A.D.R. Toxicological Profile for Chromium (2000)
36. Ray P., Devaux Y., Stolz D.B., Yarlagadda M., Watkins S.C., Lu Y., Chen L., Yang X.F., and Ray A. Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6098-6103
37. Reutershan J., and Ley K. Bench-to-bedside review: acute respiratory distress syndrome - how neutrophils migrate into the lung. Crit. Care 8 (2004) 453-461
38. Saini R.K., and Sanyal S.N. Pulmonary carcinogenesis in mice with a single intratracheal instillation of 9, 10-dimethyl benz[a]anthracene. Drug Chem. Toxicol. 31 (2008) 459-471
39. Schroeder C.P., Kadara H., Lotan D., Woo J.K., Lee H.Y., Hong W.K., and Lotan R. Involvement of mitochondrial and Akt signaling pathways in augmented apoptosis induced by a combination of low doses of celecoxib and N-(4-hydroxyphenyl) retinamide in premalignant human bronchial epithelial cells. Cancer Res. 66 (2006) 9762-9770
40. Shishodia S., Koul D., and Aggarwal B.B. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J. Immunol. 173 (2004) 2011-2022
41. Shrivastava R., Upreti R.K., Seth P.K., and Chaturvedi U.C. Effects of chromium on the immune system. FEMS Immunol. Med. Microbiol. 34 (2002) 1-7
42. Solano-Lopez C., Zeidler-Erdely P.C., Hubbs A.F., Reynolds S.H., Roberts J.R., Taylor M.D., Young S.H., Castranova V., and Antonini J.M. Welding fume exposure and associated inflammatory and hyperplastic changes in the lungs of tumor susceptible a/j mice. Toxicol. Pathol. 34 (2006) 364-372
43. Staal S.P., Hartley J.W., and Rowe W.P. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc. Natl. Acad. Sci. U. S. A. 74 (1977) 3065-3067
44. Steffee C.H., and Baettjer A.M. Histopathologic effects of chromate chemicals. Arch. Environ Health. 11 (1965) 66-75
45. Taylor M.D., Roberts J.R., Leonard S.S., Shi X., and Antonini J.M. Effects of welding fumes of differing composition and solubility on free radical production and acute lung injury and inflammation in rats. Toxicol. Sci. 75 (2003) 181-191
46. Tsurutani J., Fukuoka J., Tsurutani H., Shih J.H., Hewitt S.M., Travis W.D., Jen J., and Dennis P.A. Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors. J. Clin. Oncol. 24 (2006) 306-314
47. Van Dyke A.L., Cote M.L., Prysak G., Claeys G.B., Wenzlaff A.S., and Schwartz A.G. Regular adult aspirin use decreases the risk of non-small cell lung cancer among women. Cancer Epidemiol. Biomark. Prev. 17 (2008) 148-157
48. Wagner G.R. Asbestosis and silicosis. Lancet 349 (1997) 1311-1315
49. Wallenborn J.G., Evansky P., Shannahan J.H., Vallanat B., Ledbetter A.D., Schladweiler M.C., Richards J.H., Gottipolu R.R., Nyska A., and Kodavanti U.P. Subchronic inhalation of zinc sulfate induces cardiac changes in healthy rats. Toxicol. Appl. Pharmacol. 232 (2008) 69-77
50. Wang X.Q., Bdeir K., Yarovoi S., Cines D.B., Fang W., and Abraham E. Involvement of the urokinase kringle domain in lipopolysaccharide-induced acute lung injury. J. Immunol. 177 (2006) 5550-5557
51. West K.A., Brognard J., Clark A.S., Linnoila I.R., Yang X., Swain S.M., Harris C., Belinsky S., and Dennis P.A. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J. Clin. Invest. 111 (2003) 81-90
52. West K.A., Linnoila I.R., Belinsky S.A., Harris C.C., and Dennis P.A. Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3′-kinase/Akt pathway in vitro and in vivo. Cancer Res. 64 (2004) 446-451
53. World Health Organization International Agency for Research on Cancer (1990). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Chromium, Nickel and Welding. Lyon France.
54. Zeidler-Erdely P.C., Kashon M.L., Battelli L.A., Young S.H., Erdely A., Roberts J.R., Reynolds S.H., and Antonini J.M. Pulmonary inflammation and tumor induction in lung tumor susceptible A/J and resistant C57BL/6J mice exposed to welding fume. Part Fibre. Toxicol. 5 (2008) 12